NCT02529085View on ClinicalTrials.gov

PWS European Blood Bank for Infants and Controls From 0 to 48 Months

NACompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 1, 2017

Study Completion Date

June 1, 2017

Conditions
Prader-Willi Syndrome
Interventions
OTHER

blood samples

blood samples for the bank

Trial Locations (6)

1200

Unité d'Endocrinologie Pédiatrique / Université Catholique de Louvain, Brussels

31000

Department of Pediatrics / Division of Endocrinology, Toulouse

Unknown

Department of Endocrinology / University Children's Hospital, Essen

Karolinska University Hospital, Stockholm

3015 GJ

Department of Pediatrics / Division of Endocrinology / Erasmus University Medical Center / Sophia Children's Hospital Rotterdam, Rotterdam

W12 0NN

Metabolic & Molecular Imaging Group / MRC Clinical Sciences Centre / Imperial College London / Hammersmith Hospital, London

All Listed Sponsors
collaborator

European Society for Paediatric Endocrinology

UNKNOWN

lead

University Hospital, Toulouse

OTHER

NCT02529085 - PWS European Blood Bank for Infants and Controls From 0 to 48 Months | Biotech Hunter | Biotech Hunter